Tele: 561.316.3330
Breaking Medical Device News

Thursday, September 23, 2021
HomeCandela CorporationThe Frax Pro System Launches

The Frax Pro System Launches

January 25, 2021

The Frax Pro System, FDA-cleared, non-ablative fractional device is the first platform featuring dual-depth skin resurfacing with both Frax 1550™ and the novel Frax 1940™ applicators.

Candela today announced the availability of the Frax Pro™ system.

The two modalities target different skin layers, stimulating growth of new collagen, revealing smoother, more brilliant skin. The Frax 1940 handpiece delivers a 1940 nm wavelength laser beam for a shallow, epidermal approach, with focal reach extending to approximately 200 μm in depth. The 1550 nm wavelength of the Frax 1550 handpiece penetrates deeper, with histological analysis showing up to 800 μm penetration. Clinical studies demonstrate high rates of textural improvement and patient satisfaction with the Frax 1550 and Frax 1940 handpieces.

“With use of both applicators achieving dual depth resurfacing, we saw a complementary effect,” says Jill Waibel, MD of Miami Dermatology and Laser Institute. “Additionally, patients treated in our clinic were extremely pleased with new Frax 1940 treatment results. The outcomes clearly demonstrated intended results of skin resurfacing with improvement in both textural irregularities and skin tone.”

The Frax Pro system revolutionizes the aesthetic space by removing limitations of earlier fractional 1550 nm, 1565 nm and/or 1927 nm laser systems. High return on investment (ROI) treatments of the Frax Pro system make it a wise approach to managing practice costs when compared to a leading competitive device. The Frax Pro system’s exclusive 100% applicator-confined diode laser technology and a reductive design, allows a lightweight, flexible umbilical for a comfortable, ergonomic reach and improved treatment visibility relative to thulium-based systems.

Multiple laser scan widths enable more customized treatments. These innovations, along with magnetic roller sensing technology and integrated clinical intelligence for quick learning and data retrieval, are just some of the ways that the Frax Pro system advances the space of non-ablative fractional laser therapies, making it the “smart way to Frax”.

Both the Frax 1550 and Frax 1940 technologies are also available on, and interchangeable with, the NordlysTM platform. This addition makes the Nordlys system the first in its class to provide dual fractional 1550 nm and 1940 nm wavelengths, as well as IPL and Nd:YAG capabilities.

“The Frax Pro and Nordlys systems, both with Frax 1550 and Frax 1940 applicators, extend our legacy of innovation in non-ablative treatments,” says Geoffrey Crouse, Chief Executive Officer of Candela. “Candela has a long history of technological innovation and bringing to market best-in-class medical aesthetic energy-based devices, and we are proud to share this new offering.”

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Stay Connected

spot_img

Don't Miss

Kleiner Device Labs Receives FDA Market Clearance for KG2 Surge Flow-Thru Interbody System

The system maximizes total bone graft delivery volume, better distributes graft bilaterally into the intervertebral disc space, and streamlines the implant delivery, positioning, and grafting process for TLIF and PLIF spinal fusion procedures.

Matthew Cranfill New ExtriCARE USA Director Of Clinical Services

"Matt's impressive experience and skillset easily made him our top pick," said Peter Mason, President of ExtriCARE USA.

FDA Authorizes Software that Can Help Identify Prostate Cancer

The software is called Paige Prostate and is compatible for use with slide images that have been digitized using a scanner.

Shannon Lantzy MedCrypt New VP of Consulting

"I met Shannon at a healthcare-related event several years ago and was immediately impressed with her passion and drive to move healthcare into a digital future," said Mike Kijewski, CEO of MedCrypt.

Mark Foster Joins Xenocor BOD

Foster is a versatile and visionary C-Suite executive who brings 20 years of general management and leadership experience from both venture-backed growth-stage organizations and world-class medical device companies

Hinge Health Acquires the Most Advanced Computer Vision Technology for Tracking Human Motion

CEO Daniel Perez explained, “We won’t stop investing in technology to deliver the most patient-centered digital clinic that improves member experience and outcomes while reducing costs. wrnch allows us to take a giant leap forward in all respects.”

Dale W Wood Congratulates the Huma Team on Raising $130 Million

Major health and technology companies across the world have committed upwards of $130 million to Huma Therapeutics, the health-tech company backed by Dale Ventures.

Rhaeos Awarded $4 Million NIH SBIR Grant

Under the NIH SBIR grant, Rhaeos will leverage their existing wireless sensor hardware to provide additional quantitative flow data to the clinician, giving insight into this currently inaccessible and highly relevant shunt performance metric.

By using this website you agree to accept Medical Device News Magazine Privacy Policy